Cargando…
Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas (Observatoire dédié au Cancer Bretagne / Pays de la Loire)
BACKGROUND: In 2006, bevacizumab, a targeted therapy agent was combined with FOLFIRI for the firstline treatment of patients with unresectable metastatic colorectal cancer. METHODS/RESULTS: A study on a homogenous series of 111 patients from the Brittany and Pays de la Loire areas who received bevac...
Ejemplares similares
-
The French Musculoskeletal Disorders Surveillance Program: Pays de la Loire network
por: Ha, C, et al.
Publicado: (2009) -
Châteaux de la Loire /
por: Lanoux, Armand
Publicado: (1967) -
Trésors de saône-et-loire
por: Oursel, Raymond -
Chateaux et vallée de la Loire
por: Levron, Jacques, 1906-2004
Publicado: (1970) -
Proportion of upper extremity musculoskeletal disorders attributable to personal and occupational factors: results from the French Pays de la Loire study
por: Nambiema, Aboubakari, et al.
Publicado: (2020)